Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 5Alprolix
02 6BeneFIX
03 1Benefix
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Coagulation Factor IX (Recombinant), Fc Fusion Protein
Main Therapeutic Indication : Hematology
Currency : USD
2022 Revenue in Millions : 553
2021 Revenue in Millions : 456
Growth (%) : 21
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Coagulation Factor IX (Recombinant), Fc Fusion Protein
Main Therapeutic Indication : Rare Diseases
Currency : USD
2023 Revenue in Millions : 583
2022 Revenue in Millions : 553
Growth (%) : 7
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Coagulation Factor IX (Recombinant), Fc Fusion Protein
Main Therapeutic Indication : Blood Disorders
Currency : USD
2018 Revenue in Millions : 322
2017 Revenue in Millions : 0
Growth (%) : NA
Main Therapeutic Indication : Rare Disorders
Currency : USD
2019 Revenue in Millions : 488
2018 Revenue in Millions : 554
Growth (%) : -12
Main Therapeutic Indication : Rare Disorders
Currency : USD
2020 Revenue in Millions : 454
2019 Revenue in Millions : 488
Growth (%) : -7
Main Therapeutic Indication : Rare Disorders
Currency : USD
2021 Revenue in Millions : 438
2020 Revenue in Millions : 454
Growth (%) : -4
Main Therapeutic Indication : Rare Diseases
Currency : USD
2022 Revenue in Millions : 425
2021 Revenue in Millions : 438
Growth (%) : -3
Coagulation Factor IX (Recombinant), Fc Fusion Protein
Main Therapeutic Indication : Hematology
Currency : USD
2022 Revenue in Millions : 178
2021 Revenue in Millions : 190
Growth (%) : -6
Main Therapeutic Indication : Rare Diseases
Currency : USD
2023 Revenue in Millions : 424
2022 Revenue in Millions : 425
Growth (%) : 0
Coagulation Factor IX (Recombinant), Fc Fusion Protein
Main Therapeutic Indication : Blood Disorders
Currency : USD
2018 Revenue in Millions : 0
2017 Revenue in Millions : 26
Growth (%) : -100%
LOOKING FOR A SUPPLIER?
